Ben R. Taylor - 16 Dec 2024 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Chief Financial Officer
Signature
Jonathan D. Golightly, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
16 Dec 2024
Net transactions value
-$143,681
Form type
4
Filing time
18 Dec 2024, 18:49:14 UTC
Previous filing
02 Dec 2024
Next filing
20 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Tax liability $94,635 -15,668 -3.2% $6.04 480,924 16 Dec 2024 Direct F1
transaction RXRX Class A Common Stock Tax liability $49,046 -7,057 -1.5% $6.95 473,867 17 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.